These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20597005)

  • 1. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
    Matamouros S; England P; Dupuy B
    Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
    Dupuy B; Govind R; Antunes A; Matamouros S
    J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the pathogenicity locus in Clostridium difficile strains.
    Cohen SH; Tang YJ; Silva J
    J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus.
    Monot M; Eckert C; Lemire A; Hamiot A; Dubois T; Tessier C; Dumoulard B; Hamel B; Petit A; Lalande V; Ma L; Bouchier C; Barbut F; Dupuy B
    Sci Rep; 2015 Oct; 5():15023. PubMed ID: 26446480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
    Bakker D; Smits WK; Kuijper EJ; Corver J
    PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
    Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
    J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile.
    Elliott B; Reed R; Chang BJ; Riley TV
    Anaerobe; 2009 Dec; 15(6):249-51. PubMed ID: 19723585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spores of Clostridioides difficile are toxin delivery vehicles.
    Cassona CP; Ramalhete S; Amara K; Candela T; Kansau I; Denève-Larrazet C; Janoir-Jouveshomme C; Mota LJ; Dupuy B; Serrano M; Henriques AO
    Commun Biol; 2024 Jul; 7(1):839. PubMed ID: 38987278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of Clostridium difficile toxin gene expression by CodY.
    Dineen SS; Villapakkam AC; Nordman JT; Sonenshein AL
    Mol Microbiol; 2007 Oct; 66(1):206-19. PubMed ID: 17725558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
    Rupnik M
    FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile toxinotyping.
    Rupnik M
    Methods Mol Biol; 2010; 646():67-76. PubMed ID: 20597003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
    Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
    Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phage infection on toxin production by Clostridium difficile.
    Goh S; Chang BJ; Riley TV
    J Med Microbiol; 2005 Feb; 54(Pt 2):129-135. PubMed ID: 15673505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain.
    Ackermann G; Tang YJ; Henderson JP; Rodloff AC; Silva J; Cohen SH
    Mol Cell Probes; 2001 Oct; 15(5):301-6. PubMed ID: 11735302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.